AI Digital solution transforming care delivery by democratizing access to screening & diagnosis while providing efficient path to treatment.
Mamotest has raised $3.3M in total funding. The most recent round was Seed. The last funding was announced in March 2023.
Mamotest's investors include Merck, Sonen Capital, Merck Global Health Innovation Fund, Johnson & Johnson Impact Ventures, Sky High.
Mamotest is headquartered in Mexico City, Mexico.
AI Digital solution transforming care delivery by democratizing access to screening & diagnosis while providing efficient path to treatment.
Mamotest is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Mamotest — Funding & Investors." VCBacked, March 27, 2023, https://www.vcbacked.co/company/mamotest. Accessed September 14, 2026.
VCBacked. (2023). Mamotest — Funding & Investors. Retrieved September 14, 2026, from https://www.vcbacked.co/company/mamotest
{{cite web |title=Mamotest — Funding & Investors |url=https://www.vcbacked.co/company/mamotest |website=VCBacked |access-date=September 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated